Custom service
MHC Binding Peptide Screening
Screen candidate peptides for binding to a given hla allele before committing to tetramers
Teams come to this service when they need to screen candidate peptides for binding to a given HLA allele before committing to tetramers. We typically start from competition binding assays, add stability half-life measurement where the application demands it, and close the loop with motif-informed ranking so the final ranked binding report with half-life data behaves consistently across lots.
Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 3–5 weeks timeline holds in practice.
Neoantigen candidate triage
Epitope prioritization before tetramer spend
Screens requiring live patient material
Alleles or peptides with no published refolding precedent and no feasibility budget
Each tetramer lot is tested functionally, not just biochemically: a known antigen-specific T cell line or clone is stained, and the lot is released only if the staining profile meets the agreed specification. Allele and peptide identity are confirmed by MS.
Service Highlights
- Competition binding assays as the default route, with stability half-life measurement held as a proven fallback
- Motif-informed ranking worked into the design where the application requires it
- Refolding yield and monomer integrity confirmed by SEC before tetramerization
- Analytical confirmation of every intermediate before the final release
- Fluorescent labels chosen and titrated so staining signal stays in the linear range
- Ranked binding report with half-life data delivered with a complete conjugation or synthesis certificate
How the work runs
Construct design
Allele, peptide and biotinylation acceptor peptide are confirmed, and the expression construct strategy is agreed.
Inclusion body preparation
Heavy chain and β2-microglobulin are expressed and purified as inclusion bodies.
Refolding
Chain, β2M and peptide are folded together under redox-buffered conditions optimized for the allele.
Biotinylation & purification
Monomer is BirA-biotinylated and polished by SEC-HPLC to remove aggregates.
Tetramerization
Fluorescent streptavidin is titrated in to form stable tetramers with controlled label ratio.
Functional release
Ranked binding report with half-life data is released after flow-cytometry binding confirmation against the specification.
Specifications & timeline
- Turnaround
- 3–5 weeks
- Typical scale
- 50 µg – 1 mg tetramer per construct
- Chemistry options
- competition binding assays; stability half-life measurement; motif-informed ranking
- Deliverable
- Ranked binding report with half-life data
- QC package
- SEC-HPLC monomer integrity, biotinylation ratio, flow-cytometry binding test
- Shipping
- Dry ice, aliquoted to avoid freeze-thaw
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.